Siegel; Matthew John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Siegel; Matthew John.The latest application filed is for "methods and pharmaceutical compositions for treating celiac disease and gluten intolerance".

Company Profile

0.10.13

Siegel; Matthew John - Menlo Park CA
Siegel; Matthew John - Sunnyvale CA US
Siegel; Matthew John - San Mateo CA
Siegel; Matthew John - Stanford CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance Grant 10,434,150 - Berner , et al. O	2019-10-08
Methods and Pharmaceutical Compositions for Treating Celiac Disease and Gluten Intolerance App 20150352195 - Berner; Bret ; et al.	2015-12-10
Acid Stable Prolyl Endopeptidases for Degrading Gluten App 20150197738 - Siegel; Matthew John	2015-07-16
Formulation for oral administration of proteins Grant 8,980,254 - Siegel , et al. March 17, 2	2015-03-17
Transglutaminase inhibitors and methods of use thereof Grant 8,871,718 - Khosla , et al. October 28, 2	2014-10-28
Proteases for Degrading Gluten App 20140205587 - Siegel; Matthew John	2014-07-24
Combination enzyme therapy for digestion of dietary gluten Grant 8,778,338 - Gass , et al. July 15, 2	2014-07-15
Transglutaminase inhibitors and methods of use thereof Grant 8,470,782 - Khosla , et al. June 25, 2	2013-06-25
Transglutaminase Inhibitors And Methods Of Use Thereof App 20130102633 - Khosla; Chaitan ; et al.	2013-04-25
Formulation for Oral Administration of Proteins App 20110171201 - Siegel; Matthew John ; et al.	2011-07-14
Combination Enzyme Therapy for Digestion of Dietary Gluten App 20100092451 - Gass; Jonathan David ; et al.	2010-04-15
Transglutaminase inhibitors and methods of use thereof App 20090312272 - Khosla; Chaitan ; et al.	2009-12-17
Transglutaminase inhibitors and methods of use thereof Grant 7,579,313 - Khosla , et al. August 25, 2	2009-08-25
Peptides For Diagnostic And Therapeutic Methods For Celiac Sprue App 20090156490 - Khosla; Chaitan ; et al.	2009-06-18
Transglutaminase Inhibitors And Methods Of Use Thereof App 20090042806 - Khosla; Chaitan ; et al.	2009-02-12
Peptides for diagnostic and therapeutic methods for celiac sprue Grant 7,462,688 - Khosla , et al. December 9, 2	2008-12-09
Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue App 20080299108 - Khosla; Chaitan ; et al.	2008-12-04
Peptides for diagnostic and therapeutic methods for celiac sprue App 20060189540 - Khosla; Chaitan ; et al.	2006-08-24
Transglutaminase inhibitors and methods of use thereof App 20060052308 - Khosla; Chaitan ; et al.	2006-03-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.